Clinical trials: Risk of Aspiration

Breast Cancer

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

• Completed
• Age: 18 to 65 years
• Phase 2
• Results posted

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of LY353381 may be an effective way to prevent the development of breast cancer in women who have…

Trial name

NCT00005879

Testing

arzoxifene

Where

2 sites in United States

Volunteers

199 people, healthy volunteers welcome

Sponsor

University of Kansas Medical Center